{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:19:15Z","timestamp":1790849955454,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alternative splicing is a pivotal regulatory mechanism in cellular biology that critically influences the tumorigenesis, progression, and phenotypic diversity of cancer. This study aimed to assess the intricate details and regulatory mechanisms of alternative splicing in gastric cancer. We constructed a comprehensive map of aberrant alternative splicing events in gastric cancer through bioinformatic analysis of public databases and clinical samples. Our study identified many abnormal splicing events in gastric cancer tissues, with exon skipping being the most frequent event. SNRPB, a key spliceosome component and principal splicing factor, was associated with the aberrant splicing of numerous splicing factors and oncogenes, influencing the p53 signaling pathway in the development and progression of gastric cancer. SNRPB directly regulates the selective splicing of TP53 by modulating its downstream factor, PUF60, thus facilitating the initiation and progression of gastric cancer. Therefore, SNRPB overexpression is linked to poor prognosis in gastric cancer and is a potential biomarker and therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-025-08011-2","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:28:55Z","timestamp":1759825735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SNRPB promotes gastric cancer progression by regulating aberrant splicing of PUF60"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3492-203X","authenticated-orcid":false,"given":"Dan","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9287-1765","authenticated-orcid":false,"given":"Jiaxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaofang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianfeng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangkai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3646-9778","authenticated-orcid":false,"given":"Xiaoming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7974-830X","authenticated-orcid":false,"given":"Xian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3241-5282","authenticated-orcid":false,"given":"Xiangyang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8307-2389","authenticated-orcid":false,"given":"Tanzhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"8011_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"8011_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023\u201375.","journal-title":"Lancet"},{"key":"8011_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/den.13531","volume":"32","author":"W Hatta","year":"2020","unstructured":"Hatta W, Gotoda T, Koike T, Masamune A. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc. 2020;32:180\u201390.","journal-title":"Dig Endosc"},{"key":"8011_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1001\/jamaoncol.2020.3152","volume":"6","author":"F Liu","year":"2020","unstructured":"Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, et al. Morbidity and mortality of laparoscopic vs open total gastrectomy for clinical stage I gastric cancer: the CLASS02 multicenter randomized clinical trial. JAMA Oncol. 2020;6:1590\u20137.","journal-title":"JAMA Oncol"},{"key":"8011_CR5","doi-asserted-by":"publisher","first-page":"lqaa013","DOI":"10.1093\/nargab\/lqaa013","volume":"2","author":"S Cheng","year":"2020","unstructured":"Cheng S, Ray D, Lee RTH, Naripogu KB, Yusoff P, Goh PBL, et al. A functional network of gastric-cancer-associated splicing events controlled by dysregulated splicing factors. NAR Genom Bioinform. 2020;2:lqaa013.","journal-title":"NAR Genom Bioinform"},{"key":"8011_CR6","first-page":"7247","volume":"63","author":"JH Lee","year":"2003","unstructured":"Lee JH, Seo YW, Park SR, Kim YJ, Kim KK. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression. Cancer Res. 2003;63:7247\u201355.","journal-title":"Cancer Res"},{"key":"8011_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33786-9","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee J, Pang K, Kim J, Hong E, Lee J, Cho HJ, et al. ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. Nat Commun. 2022;13:6274.","journal-title":"Nat Commun"},{"key":"8011_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1158\/0008-5472.CAN-21-2117","volume":"82","author":"Y Jun","year":"2022","unstructured":"Jun Y, Suh YS, Park S, Lee J, Kim JI, Lee S, et al. Comprehensive analysis of alternative splicing in gastric cancer identifies epithelial-mesenchymal transition subtypes associated with survival. Cancer Res. 2022;82:543\u201355.","journal-title":"Cancer Res"},{"key":"8011_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.04.016","volume":"98","author":"C Branco da Cunha","year":"2016","unstructured":"Branco da Cunha C, Klumpers DD, Koshy ST, Weaver JC, Chaudhuri O, Seruca R, et al. CD44 alternative splicing in gastric cancer cells is regulated by culture dimensionality and matrix stiffness. Biomaterials. 2016;98:152\u201362.","journal-title":"Biomaterials"},{"key":"8011_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7042","volume":"6","author":"V Madan","year":"2015","unstructured":"Madan V, Kanojia D, Li J, Okamoto R, Sato-Otsubo A, Kohlmann A, et al. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun. 2015;6:6042.","journal-title":"Nat Commun"},{"key":"8011_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0990-4","volume":"17","author":"BR Correa","year":"2016","unstructured":"Correa BR, de Araujo PR, Qiao M, Burns SC, Chen C, Schlegel R, et al. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma. Genome Biol. 2016;17:125.","journal-title":"Genome Biol"},{"key":"8011_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1929-y","volume":"10","author":"N Liu","year":"2019","unstructured":"Liu N, Wu Z, Chen A, Wang Y, Cai D, Zheng J, et al. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26. Cell Death Dis. 2019;10:667.","journal-title":"Cell Death Dis"},{"key":"8011_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01502-0","volume":"38","author":"N Liu","year":"2021","unstructured":"Liu N, Chen A, Feng N, Liu X, Zhang L. SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer. Med Oncol. 2021;38:57.","journal-title":"Med Oncol"},{"key":"8011_CR14","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/cbin.11307","volume":"44","author":"N Peng","year":"2020","unstructured":"Peng N, Li J, He J, Shi X, Huang H, Mo Y, et al. c-Myc-mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinoma. Cell Biol Int. 2020;44:1103\u201311.","journal-title":"Cell Biol Int"},{"key":"8011_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.18632\/aging.202164","volume":"13","author":"YT Zhan","year":"2020","unstructured":"Zhan YT, Li L, Zeng TT, Zhou NN, Guan XY, Li Y. SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma. Aging. 2020;13:537\u201354.","journal-title":"Aging"},{"key":"8011_CR16","doi-asserted-by":"publisher","first-page":"109948","DOI":"10.1016\/j.biopha.2020.109948","volume":"125","author":"L Zhu","year":"2020","unstructured":"Zhu L, Zhang X, Sun Z. SNRPB promotes cervical cancer progression through repressing p53 expression. Biomed Pharmacother. 2020;125:109948.","journal-title":"Biomed Pharmacother"},{"key":"8011_CR17","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1017\/S1355838299991938","volume":"5","author":"PS Page-McCaw","year":"1999","unstructured":"Page-McCaw PS, Amonlirdviman K, Sharp PA. PUF60: a novel U2AF65-related splicing activity. RNA. 1999;5:1548\u201360.","journal-title":"RNA"},{"key":"8011_CR18","doi-asserted-by":"publisher","first-page":"e1004289","DOI":"10.1371\/journal.pgen.1004289","volume":"10","author":"FY Zong","year":"2014","unstructured":"Zong FY, Fu X, Wei WJ, Luo YG, Heiner M, Cao LJ, et al. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet. 2014;10:e1004289.","journal-title":"PLoS Genet"},{"key":"8011_CR19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/hep.27218","volume":"60","author":"M Malz","year":"2014","unstructured":"Malz M, Bovet M, Samarin J, Rabenhorst U, Sticht C, Bissinger M, et al. Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma. Hepatology. 2014;60:1241\u201350.","journal-title":"Hepatology"},{"key":"8011_CR20","doi-asserted-by":"publisher","first-page":"113041","DOI":"10.1016\/j.celrep.2023.113041","volume":"42","author":"N Xu","year":"2023","unstructured":"Xu N, Ren Y, Bao Y, Shen X, Kang J, Wang N, et al. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C. Cell Rep. 2023;42:113041.","journal-title":"Cell Rep"},{"key":"8011_CR21","doi-asserted-by":"publisher","first-page":"568015","DOI":"10.3389\/fonc.2020.568015","volume":"10","author":"Q Long","year":"2020","unstructured":"Long Q, An X, Chen M, Wang N, Sui S, Li Y, et al. PUF60\/AURKA axis contributes to tumor progression and malignant phenotypes in bladder cancer. Front Oncol. 2020;10:568015.","journal-title":"Front Oncol"},{"key":"8011_CR22","doi-asserted-by":"publisher","first-page":"82493","DOI":"10.18632\/oncotarget.12696","volume":"7","author":"S Kobayashi","year":"2016","unstructured":"Kobayashi S, Hoshino T, Hiwasa T, Satoh M, Rahmutulla B, Tsuchida S, et al. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients. Oncotarget. 2016;7:82493\u2013503.","journal-title":"Oncotarget"},{"key":"8011_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrg2776","volume":"11","author":"H Keren","year":"2010","unstructured":"Keren H, Lev-Maor G, Ast G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet. 2010;11:345\u201355.","journal-title":"Nat Rev Genet"},{"key":"8011_CR24","doi-asserted-by":"publisher","first-page":"e1476","DOI":"10.1002\/wrna.1476","volume":"9","author":"LM Urbanski","year":"2018","unstructured":"Urbanski LM, Leclair N, Anczuk\u00f3w O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018;9:e1476.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"8011_CR25","doi-asserted-by":"publisher","first-page":"211.e6","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles A, Lehmann KV, Toussaint NC, H\u00fcser M, Stark SG, Sachsenberg T, et al. Comprehensive analysis of alternative splicing across tumors from 8,705 patients. Cancer Cell. 2018;34:211.e6\u201324.e6.","journal-title":"Cancer Cell"},{"key":"8011_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01226-y","volume":"15","author":"Q Sun","year":"2023","unstructured":"Sun Q, Han Y, He J, Wang J, Ma X, Ning Q, et al. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer. Genome Med. 2023;15:76.","journal-title":"Genome Med"},{"key":"8011_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15921","volume":"8","author":"BD Wang","year":"2017","unstructured":"Wang BD, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, et al. Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun. 2017;8:15921.","journal-title":"Nat Commun"},{"key":"8011_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/hep.30158","volume":"69","author":"S Li","year":"2019","unstructured":"Li S, Hu Z, Zhao Y, Huang S, He X. Transcriptome-wide analysis reveals the landscape of aberrant alternative splicing events in liver cancer. Hepatology. 2019;69:359\u201375.","journal-title":"Hepatology"},{"key":"8011_CR29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1101\/gr.246678.118","volume":"29","author":"H Dvinge","year":"2019","unstructured":"Dvinge H, Guenthoer J, Porter PL, Bradley RK. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing. Genome Res. 2019;29:1591\u2013604.","journal-title":"Genome Res"},{"key":"8011_CR30","doi-asserted-by":"crossref","unstructured":"Will CL, L\u00fchrmann R. Spliceosome structure and function. Cold Spring Harb Perspect Biol. 2011;3:a003707.","DOI":"10.1101\/cshperspect.a003707"},{"key":"8011_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12484","volume":"51","author":"N Dou","year":"2018","unstructured":"Dou N, Yang D, Yu S, Wu B, Gao Y, Li Y. SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression. Cell Prolif. 2018;51:e12484.","journal-title":"Cell Prolif"},{"key":"8011_CR32","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1111\/j.1582-4934.2008.00244.x","volume":"12","author":"Z Li","year":"2008","unstructured":"Li Z, P\u00fctzer BM. Spliceosomal protein E regulates neoplastic cell growth by modulating expression of cyclin E\/CDK2 and G2\/M checkpoint proteins. J Cell Mol Med. 2008;12:2427\u201338.","journal-title":"J Cell Mol Med"},{"key":"8011_CR33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/sj.cdd.4401196","volume":"10","author":"KC Malmegrim de Farias","year":"2003","unstructured":"Malmegrim de Farias KC, Saelens X, Pruijn GJ, Vandenabeele P, van Venrooij WJ. Caspase-mediated cleavage of the U snRNP-associated Sm-F protein during apoptosis. Cell Death Differ. 2003;10:570\u20139.","journal-title":"Cell Death Differ"},{"key":"8011_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/humu.22729","volume":"36","author":"S Bacrot","year":"2015","unstructured":"Bacrot S, Doyard M, Huber C, Alibeu O, Feldhahn N, Lehalle D, et al. Mutations in SNRPB, encoding components of the core splicing machinery, cause cerebro-costo-mandibular syndrome. Hum Mutat. 2015;36:187\u201390.","journal-title":"Hum Mutat"},{"key":"8011_CR35","doi-asserted-by":"publisher","first-page":"994440","DOI":"10.3389\/fmolb.2022.994440","volume":"9","author":"J Wu","year":"2022","unstructured":"Wu J, Lu F, Yu B, Wang W, Ye X. The oncogenic role of SNRPB in human tumors: A pan-cancer analysis. Front Mol Biosci. 2022;9:994440.","journal-title":"Front Mol Biosci"},{"key":"8011_CR36","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41388-022-02177-1","volume":"41","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Zhang X, Jiang CQ, Zhang YG, Wu X, Li J, et al. Identifying novel therapeutic targets in gastric cancer using genome-wide CRISPR-Cas9 screening. Oncogene. 2022;41:2069\u201378.","journal-title":"Oncogene"},{"key":"8011_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1101\/gad.2004811","volume":"25","author":"AL Saltzman","year":"2011","unstructured":"Saltzman AL, Pan Q, Blencowe BJ. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 2011;25:373\u201384.","journal-title":"Genes Dev"},{"key":"8011_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1097-2765(00)80428-1","volume":"5","author":"J Liu","year":"2000","unstructured":"Liu J, He L, Collins I, Ge H, Libutti D, Li J, et al. The FBP interacting repressor targets TFIIH to inhibit activated transcription. Mol Cell. 2000;5:331\u201341.","journal-title":"Mol Cell"},{"key":"8011_CR39","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/path.4588","volume":"237","author":"B M\u00fcller","year":"2015","unstructured":"M\u00fcller B, Bovet M, Yin Y, Stichel D, Malz M, Gonz\u00e1lez-Vallinas M, et al. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells. J Pathol. 2015;237:390\u2013401.","journal-title":"J Pathol"},{"key":"8011_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cas.12058","volume":"104","author":"T Kajiwara","year":"2013","unstructured":"Kajiwara T, Matsushita K, Itoga S, Tamura M, Tanaka N, Tomonaga T, et al. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues. Cancer Sci. 2013;104:149\u201356.","journal-title":"Cancer Sci"},{"key":"8011_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/CMAR.S180242","volume":"11","author":"D Sun","year":"2019","unstructured":"Sun D, Lei W, Hou X, Li H, Ni W. PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression. Cancer Manag Res. 2019;11:821\u201330.","journal-title":"Cancer Manag Res"},{"key":"8011_CR42","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.7150\/ijbs.45115","volume":"16","author":"Q Long","year":"2020","unstructured":"Long Q, Hua Y, He L, Zhang C, Sui S, Li Y, et al. Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase. Int J Biol Sci. 2020;16:3002\u201317.","journal-title":"Int J Biol Sci"},{"key":"8011_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tips.2004.02.009","volume":"25","author":"LJ Hofseth","year":"2004","unstructured":"Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci. 2004;25:177\u201381.","journal-title":"Trends Pharmacol Sci"},{"key":"8011_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","volume":"14","author":"J Hu","year":"2021","unstructured":"Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B, et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol. 2021;14:157.","journal-title":"J Hematol Oncol"}],"updated-by":[{"DOI":"10.1038\/s41419-026-08783-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000}}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08011-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:03:39Z","timestamp":1778742219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8011"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08011-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: There were some mistakes in Figure 6G-I: Figure 6G, a figure layout mistake in the migration and invasion images Figure 6H-I are the statistical graphs corresponding to Figure 6G, which have been re-statistically analyzed.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41419-026-08783-1","URL":"https:\/\/doi.org\/10.1038\/s41419-026-08783-1","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the Animal Experimental Ethical Inspection of Laboratory Animal Centre, Wenzhou Medical University (wydw2021-0126), and the Ethics Committee of Wenzhou Medical University (2020-014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"709"}}